The Discounted Cash Flow (DCF) valuation of Syndax Pharmaceuticals Inc (SNDX) is (130.59) USD. With the latest stock price at 10.12 USD, the upside of Syndax Pharmaceuticals Inc based on DCF is -1390.4%.
Based on the latest price of 10.12 USD and our DCF valuation, Syndax Pharmaceuticals Inc (SNDX) is a sell. selling SNDX stocks now will result in a potential gain of 1390.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.7% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (466.42) - (79.01) | (130.59) |
| Upside | -4708.9% - -880.7% | -1390.4% |